Featured Services

The ADE Assay delivers the results from three endpoints: in vitro hepatotoxicity; CYP3A inhibition, CYP3A induction as early as 2 weeks from chemical receipt to keep up with the pace of your projects. Human hepatocytes, the GOLD standard for ADME-tox studies, are used in delivering fast results.

You will receive a report containing:
1. Results from 11 test article concentrations;
2. Statistical analysis of triplicate determinations;
3. Comparison of test article results with positive and negative controls

IVAL’s ADE Assay is currently offered at a highly competitive introductory price. Learn more with a sample protocol and pricing.

FEATURED SERVICES

Time is money. With our expedited services, results are available to you in a few short weeks. You can obtain full structural elucidation of each metabolite using comprehensive LC-MS/MS techniques. Available test systems include
hepatocytes, microsomes, S9 and others. Learn more.

The only provider of research services using the patented IdMOC technology. The IdMOC assay allows for cells or slices from multiple organs to be co-cultured as physically separated entities interconnected with an overlying medium providing successful models of normal and tumor bearing man.
Learn more.

IdMOC: Integrated Discrete Multiple Organ Co-Culture

Speeding Ahead with Metabolite
Profiling/Identification

Human Hepatocyte Adverse Drug Effects Assay
(ADE Assay)